Results 221 to 230 of about 245,637 (381)

SYSTEMATIC REVIEWS TO HELP GUIDE CLINICAL PRACTICE IN NEUROMUSCULAR DISEASE [PDF]

, 2003
Kate Jewitt, Richard AC Hughes
openalex   +1 more source

Prenatal Diagnosis and Prognostic Factors in Fetuses With Arthrogryposis Multiplex Congenita—A Systematic Review

Journal of Clinical Ultrasound, EarlyView.
Arthrogryposis Multiplex Congenita (AMC) is characterized by the presence of multiple joint contractures in the fetus' body. The diagnosis of arthrogryposis is complex and often missed prenatally. This comprehensive review of the literature published over the last 20 years, with an emphasis on the role of prenatal ultrasound in predicting postnatal ...
Mario Brock Leao, Marianna Facchinetti Brock, Jorge Roberto Di Tommaso Leao, Gianpaolo Grisolia, Mario Lituania, Samantha Erin Neumann, Gabriele Tonni, Rodrigo Ruano   +7 more
wiley   +1 more source

Mechanical insufflation-exsufflation use in neuromuscular disease: a single centre cohort study. [PDF]

BMJ Open Respir Res
Shah NM, Kaltsakas G, Madden-Scott S, Apps C, Sheridan S, Ramsay M, Srivastava S, Suh ES, D'Cruz R, Mackie M, Weston N, Hart N, Murphy P.   +12 more
europepmc   +1 more source

Respiratory muscle training in neuromuscular disease: a systematic review and meta-analysis. [PDF]

Eur Respir Rev, 2022
Watson K, Egerton T, Sheers N, Retica S, McGaw R, Clohessy T, Webster P, Berlowitz DJ.   +7 more
europepmc   +1 more source

Pressure Support Versus Assisted Controlled Noninvasive Ventilation in Neuromuscular Disease [PDF]

, 2004
Karim Chadda, Bernard Clair, David Orlikowski, Gilles Macadoux, Jean Claude Raphaël, Frédéric Lofaso   +5 more
openalex   +1 more source

Things We Do for No Reason™: Arterial blood gas testing to screen for hypercarbic respiratory failure

Journal of Hospital Medicine, EarlyView.
Abstract Venous blood gases (VBGs) are safe and effective at screening for hypercarbic respiratory failure. Multiple studies have validated that a VBG with a PvCO2 less than 45 reliably rules out hypercarbia. The use of VBGs for the initial screening of hypercarbia when hypercarbic respiratory failure is suspected can reduce the overall use of arterial
Mary E. Lacy, Lisa Saa, Zachary Bruss, Leonard Noronha   +3 more
wiley   +1 more source

Therapeutic targeting of RNA for neurological and neuromuscular disease. [PDF]

Genes Dev
Bubenik JL, Scotti MM, Swanson MS.
europepmc   +1 more source

Optically pumped magnetometers detect altered maximal muscle activity in neuromuscular disease. [PDF]

Front Neurosci, 2022
Semeia L, Middelmann T, Baek S, Sometti D, Chen H, Grimm A, Lerche H, Martin P, Kronlage C, Braun C, Broser P, Siegel M, Breu MS, Marquetand J.   +13 more
europepmc   +1 more source

Genetically‐targeted control of the spinal cord and peripheral nervous system

Journal of Intelligent Medicine, EarlyView.
Application of genetically‐targeted stimulation for treating diseases or injuries outside the brain. Optogenetic and chemogenetic systems have been developed for dysfunction in the cochlea, spinal cord, dorsal root ganglia (DRGs), peripheral nerves, lower urinary tract, and enteric nervous system (ENS). Created with Biorender.com.
Anakaren Romero Lozano, Victoria Koptelova, Zoya Ahmad, Huiliang (Evan) Wang   +3 more
wiley   +1 more source

Boosting BDNF in muscle rescues impaired axonal transport in a mouse model of DI-CMTC peripheral neuropathy

Neurobiology of Disease
Charcot-Marie-Tooth disease (CMT) is a genetic peripheral neuropathy caused by mutations in many functionally diverse genes. The aminoacyl-tRNA synthetase (ARS) enzymes, which transfer amino acids to partner tRNAs for protein synthesis, represent the ...
Elena R. Rhymes, Rebecca L. Simkin, Ji Qu, David Villarroel-Campos, Sunaina Surana, Yao Tong, Ryan Shapiro, Robert W. Burgess, Xiang-Lei Yang, Giampietro Schiavo, James N. Sleigh   +10 more
doaj